EU Authorizes use of Remdesivir to Treat Coronavirus


The European Union has approved the use of remdesivir to treat severe cases of Coronavirus.

The announcement was made on Friday 3 July, days after the US effectively stockpiled the world’s entire supply of the antiviral medication. Its approval came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.

EU Authorizes use of Remdesivir to Treat Coronavirus

EU Health Commissioner Stella Kyriakides said in a statement;
“Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.

“We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.”

Consultant Cadre Implementation, Improved Welfare for Members, my Key Priorities –New AHAPN Chairman

Remdesivir, which is the only anti-Coronavirus medication to be given the green light in the EU, was originally intended as a treatment for Ebola. It was approved in UK at the end of May, with health officials outlining that it would only be used to treat the sickest patients. It is one of two drugs approved in Britain to treat COVID-19, the other being a cheap steroid called dexamethasone.


Please enter your comment!
Please enter your name here